Stock Analysis & Valuation Sionna Therapeutics, Inc. (SION)

• Previous Close: $39.15
• Sector Valuation Confidence Level: High

Valuation method	Value, $	Upside, %
Artificial intelligence (AI)	n/a	n/a
Intrinsic value (DCF)		n/a
Graham-Dodd Method		n/a
Graham Formula		n/a

Company Information

https://www.sionnatx.com

21 Hickory Drive Suite 500

Waltham, MA 02451

United States

Phone: [phone]

Industry: Biotechnology

Sector: Healthcare

CEO: Michael Cloonan

Full Time Employees: 41

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.